22 May 2013
Keywords: cambridge, neuroscience, gains, fda, approval, received, food
Article | 01 March 1993
- Cambridge Neuroscience has received approval from the US Food and Drug
Administration to begin Phase I trials of Cerestat for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
21 May 2013
© 2013 thepharmaletter.com